Ekso Bionics (EKSO) Tops Q1 EPS by 2c

Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $2.38 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance